Back to results

CompletedPhase 4

Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation

NCT01841242

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

CH d'Aix en Provence

Aix-en-Provence, France

+23 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2013-04-23
Enrollment: 2,272 participants
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Purpose: prevention

Locations (24)

CH d'Aix en ProvenceAix-en-Provence, France
CHU d'AmiensAmiens, France
CHU d'AngersAngers, France
CH d'AnnecyAnnecy, France
CH d'AvignonAvignon, France
CHU de BordeauxBordeaux, France
CHU de BrestBrest, France
CHU de CaenCaen, France
CH de ChartresChartres, France
CHU de Clermont-FerrandClermont-Ferrand, France
CHU de DijonDijon, France
CHU de GrenobleGrenoble, France
CH la RochelleLa Rochelle, France
CHU de LilleLille, France
Ch St Joseph St LucLyon, France
AP-HMMarseille, France
CHU de MontpellierMontpellier, France
CHU de NimesNîmes, France
CH de PérigueuxPérigueux, France
CHU de ReimsReims, France
CHU de RouenRouen, France
CHU de Saint-EtienneSaint-Etienne, France
CHU de StrasbourgStrasbourg, France
CHU de ToulouseToulouse, France

Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation — TrialFind